fda approves first oral glp-1 obesity drug august 21 2025 US regulators approve Wegovy pill, medication to treat | US healthcare US approves first GLP-1 pill

Critical nodes in signalling pathways: Insights into insulin action

[DOI] [PubMed] [Google Scholar] 65.Nauck M.A., Meier J.J

Overall pipeline momentum is unprecedented for metabolic disease

Dcruz, J

Equity Considerations : Efforts must be made to ensure equitable access to these therapies while addressing cost and insurance coverage barriers

Additionally, both semaglutide and tirzepatide showed promise in improving metabolic dysfunction-associated steatotic liver disease (MASLD), mitigating systemic inflammation, and contributing to improvements in liver-related outcomes, including steatosis resolution and fibrosis-related endpoints, in clinical trials